Article Details
Retrieved on: 2024-06-22 14:49:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Neo Ivy Capital Management acquired a new stake in shares of Arrowhead Pharmaceuticals in the fourth quarter valued at approximately $41,000.
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here